In our latest Healthcare Market Update we look at: Roivant’s continuing charge, AstraZeneca’s dealmaking, and one year on, the evolution of CAR-T therapies.

In our latest Healthcare Market Update we look at: Roivant’s continuing charge, AstraZeneca’s dealmaking, and one year on, the evolution of CAR-T therapies.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.